The "Gene Synthesis: Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.
This report explores critical trends in the gene synthesis market, including the market drivers and restraints, R&D spending, increasing competition, new technologies, product launches and therapeutic applications. It explores the drivers and challenges influencing the market dynamics, along with an analysis of emerging technologies and new developments shaping the gene synthesis landscape.
Merger and acquisition (M&A) activity and partnerships between companies are also discussed. In this report, the global market for gene synthesis is segmented by method, services, application, end user and region. Companies considering expanding their geographic reach will find the coverage of the regional markets helpful.
Additionally, the report discusses the evolving landscape of Environmental, Social, and Governance (ESG) factors, including consumer attitudes, impact on company performance, analysis of companies' ESG scores, and future trends in ESG practices. Furthermore, it analyzes the vendor landscape, including company market shares, recent mergers and acquisitions (M&A) activity, and the outlook for venture funding, providing a comprehensive overview of the gene synthesis market.
Report Includes
- A discussion of the global market trends, with current and historical market revenue (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- An evaluation of the market size and revenue forecast for the global gene synthesis market, and corresponding market share analysis by method, services, application, end user and region
- A look at the drivers and challenges that affect the global market
- An analysis of the emerging technologies and new developments in the gene synthesis market
- A discussion of ESG developments, including consumer attitudes, the impact of ESG on company performance, analysis of companies' ESG scores and the future of ESG, and ESG practices of leading companies
- An analysis of the vendor landscape, including the company market shares, recent M&A activity and the outlook for venture funding
- Company profiles of major players within the industry, including GenScript, Eurofins Scientific, Thermo Fisher Scientific Inc., Merck KGaA, and Azenta US Inc.
Company Profiles
- Azenta US Inc.
- Danaher Corp.
- Eurofins Scientific
- GenScript
- Merck KGaA
- Origene Technologies Inc.
- Promab Biotechnologies Inc.
- Proteogenix
- Thermo Fisher Scientific Inc.
- Twist Bioscience
Key Attributes:
Report Attribute | Details |
No. of Pages | 91 |
Forecast Period | 2023 - 2028 |
Estimated Market Value (USD) in 2023 | $2 Billion |
Forecasted Market Value (USD) by 2028 | $4.1 Billion |
Compound Annual Growth Rate | 15.8% |
Key Topics Covered:
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview of Gene Synthesis
- Gene Synthesis Methods
- Gene Synthesis Applications
- Scientific Advances in Gene Synthesis
- Technological Innovation in Gene Synthesis
- Ethical Considerations in Gene Synthesis
- Societal Implications
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Biopharmaceutical R&D
- Diagnostic and Therapeutic Applications
- Advances in Agrobiotechnology
- DNA Data Storage and Synthetic Genomics
- Advances and Cost Reductions in Technology
- Rising Investments in R&D
- Opportunities in Personalized Medicine
- Restraints
- Cost Constraints
- Lack of Quality Control and Standardization
- Opportunities
- Personalized Medicine and Precision Healthcare
- AI in Gene Synthesis
- Challenges
- Intellectual Property Issues
- Long Turnaround Times
Chapter 4 Regulatory Landscape
- Biosecurity and Dual-use Concerns
- Export Controls and Trade Regulations
- Intellectual Property Rights
- Regulatory Oversight of Clinical Applications
- Ethical and Societal Considerations
- Quality Assurance and Product Standards
- Regulatory Challenges by Country
- United States
- Canada
- Europe
- Japan
- India
- Brazil
Chapter 5 Emerging Technologies and Developments
- Enzymatic DNA Synthesis
- Microfluidic DNA Synthesis
- Machine Learning and AI
- Thermodynamically Balanced Inside-out
- Ligase-based Gene Synthesis
- Polymerase-based Gene Synthesis
- Patent Analysis
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Gene Synthesis: Global Market
- Global Market for Gene Synthesis, by Method
- Solid-phase Synthesis
- PCR-based Enzyme Synthesis
- Chip-based Synthesis
- Global Market for Gene Synthesis, by Services
- Antibody DNA Synthesis
- Viral DNA Synthesis
- Other Gene Synthesis Services
- Gene Synthesis: Global Markets, by Application
- Gene and Cell Therapy Development
- Vaccine Development
- Disease Diagnosis
- Other Applications
- Global Market for Gene Synthesis, by End User
- Academic and Government Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Geographic Breakdown
- In-house or Outsource?
- Cost Considerations
- Quality Control and Assurance
- Convenience and Turnaround Time
- Customization and Specialization
- Strategic Considerations
Chapter 7 Competitive Landscape
- Company Rankings
- M&A and Venture Funding
- In Summation
Chapter 8 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/7c7lve
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240516322596/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900